Cargando…
Retrospective analysis of low-dose interleukin-2 therapy on chronic autoimmune thyroid disease with concurrent systemic lupus erythematosus
INTRODUCTION: Low-dose interleukin-2 (IL-2) regulates the homeostasis of CD4(+) T cells by modulating the proportions of effector and regulatory T cells, thus reducing disease activity in patients with systemic lupus erythematosus (SLE). However, to date, no research has been carried out on the effi...
Autores principales: | Wang, Naidi, Jin, Yuebo, Cheng, Gong, Zhang, Kai, Huang, Bo, Li, Yuhui, He, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10392266/ https://www.ncbi.nlm.nih.gov/pubmed/37489616 http://dx.doi.org/10.1080/07853890.2023.2238600 |
Ejemplares similares
-
Intravenous Immunoglobulin in the Management of Lupus Erythematosus Panniculitis
por: AlQadri, Nada G, et al.
Publicado: (2020) -
Evans Syndrome in the Context of Incomplete Systemic Lupus Erythematosus
por: Abu Kar, Sarah, et al.
Publicado: (2022) -
Assessment of Mean Platelet Volume in Patients with Systemic Lupus Erythematosus
por: Hartmann, Lisandra Torres, et al.
Publicado: (2018) -
Chylous Ascites in Systemic Lupus Erythematosus: A Diagnostic Challenge
por: Hasan, Badar, et al.
Publicado: (2017) -
A Practical Perspective of the Hematologic Manifestations of Systemic Lupus Erythematosus
por: Santacruz, Juan Camilo, et al.
Publicado: (2022)